aser and LED on the healing of cardiac surgery incisio

Phase 1

• Conditions: Healing, dehiscence, pain, inflammation, infection; C23.550.767.887; G16.100.856.891; E04.100.376.719

• Registration Number: RBR-38wgx6
• Lead Sponsor: Faculdade Novafapi

Brief Summary

Not available

Detailed Description

Not available

Study Timeline

• Results First Posted: 1900-01-01
• Study Start: 2012-05-01
• Last Update Posted: 29 May 2023

Recruitment & Eligibility

• Status: Recruitment completed
• Sex: Not specified
• Target Recruitment: Not specified

Inclusion Criteria

Were included individuals who perform elective coronary artery bypass grafting with saphenous vein graft, undergoing cardiopulmonary bypass, hemodynamically stable and who agree to participate in the study by signing the Consent Term.

Exclusion Criteria

Diabetic, morbidly obese with a body mass index (BMI) greater than 40 kg/m2, history of previous thoracic surgery, urgent and emergency surgery, respiratory failure, renal failure, low cardiac output syndrome, need for circulatory assistance using of intra-aortic balloon, subjects who developed complications that resulted in changes to the protocol of analgesia, those showing the period of preoperative hospitalization over 48 hours, presence of coagulopathy, malignancy, renal failure, respiratory tract infections, urinary and endocarditis, as well as those who refused to participate.

Study & Design

• Study Type: Intervention
• Study Design: Not specified